Disease outline PML accompanied DMF is a dubious disease in the area of the nervous system, with clinical performance being complex and often involving multi-system congestion. Early identification and standardized clinical care are essential for improving prognosis. Diagnosis of the disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological activation.
Platforms can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Individualised development of treatment programs for treatment and management of PML accompanied DMF usually includes drug therapy, rehabilitation interventions, and regular follow-up multi-dimensional management. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many neurological diseases that have been difficult to treat have been significantly improved.
Treatment needs to be closely monitored for effectiveness and adverse reactions, adjusted in a timely manner according to the changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of PML-associated DMF. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.